Abstract
Bibliometrics methods are commonly used to analyse and compare scientific performance. At present there are no bibliometric analyses on insulin resistance (IR) publications. In this study, we analysed highly-cited IR publications. The analysis presented is based on Web of Science (WoS): Science Citation Index Expanded. Total citations (TC), citation in latest year, citation per publication, number of authors, and collaborations were analysed. Most productive institutes and authors were also identified. Our search identified 103,742 documents including 72,909 articles related to IR. A total of 167 highly-cited documents (0.016% of 103,742 documents) with TC 2019 of≥1,000 in IR research were identified inclusive of 124 highly-cited articles, which were all written in English. These highly-cited documents were mainly published in the journal Nature and for most of them, the WoS category was “multidisciplinary-sciences”. United States of America was the country which has published most number of the highly-cited publications. Harvard University held the highest rank with the most number of highly-cited papers. Collaborative multidisciplinary research were common in the field of IR. Majority of the publications were arising from developed countries and highly-ranked institutions. More research should be encouraged in developing countries where IR remains a significant issue. • Collaborative multidisciplinary research were common in the field of insulin resistance. • Common research fields of insulin resistance publications identified focused on identification and molecular mechanisms. • Publications on its role in the pathogenesis of a plethora of metabolic diseases were also common. • Majority of the publications were arising from developed countries and highly-ranked institutions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.